CAR T-cell therapy in hard-to-treat multiple myeloma produces sustained remissions

Share :
Published: 7 Dec 2019
Views: 1068
Dr Yu Hu - Huazhong University of Science and Technology, Wuhan, China

Dr Yu Hu presents data from a study looking at bispecific CAR-T Cell therapy in patients with multiple myeloma during a press conference at ASH 2019.

The study evaluated the sustainability of remissions in this hard to treat multiple myeloma.

Read more about the study here

Watch our interview with Dr Yu Hu here